2 November 2021 - Personalized medicine

The EUCROF Events & Training Working Group is pleased to present the Training, which can be attended either in presence or virtually, on

Personalised Medicine
Current Applications in Clinical Research 
and Regulatory Framework

Date & Time: 2 November 2021 from 9:00 AM to 17:00 PM (CET)

Where: Munich (Germany)
Attendees: Medical Directors, Senior Researchers, Project Managers, Investigators, Biostatisticians, Regulatory Experts, Scientific Societies and Patients Associations and any other person interested in Personalised Medicines Applications Clinical Research.
Attendance Fee for attending the meeting in presence:
€ 450 (for EUCROF members € 300)
Attendance Fee for attending the meeting virtually:
€ 225 (for EUCROF members € 150) 

For further information and to register, kindly write a message to
Ms Assia Rosati (This email address is being protected from spambots. You need JavaScript enabled to view it.).

Training Objectives:
  • Provide an overview of Personalised Medicine and its current applications in clinical research.
  • Explain personalised medicine principles, the development and use of biomarkers and the impact of pharmacogenomics that will be illustrated by a series of case studies. 
  • Allow participants to be more familiar with clinical trial design, the EU regulatory framework and the ethical challenges in the era of personalised medicine. 
  • Emphasize the application of personalised medicine in the paediatric population, where identifying new innovative treatments is more challenging.  


 Programme of the course:  

Session I: An overview and the current applications of personalised medicine
09:20 – 10:00 Personalised medicine and pharmacokinetic modelling and simulation in paediatric and adult population Youssef Daali (Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, Switzerland)
10:00 – 10:40 Personalised medicine current applications and the future: adults and paediatric case studies. Oscar Della Pasqua (TEDDY European Network of Excellence for Paediatric Research, Italy)
10:40 – 11:00 Break  
Session II: The use of biomarkers in personalised medicine
11:00 – 11:40 The application of biomarkers to improve patient outcomes and their validation Alain van Gool (Translational Metabolic Laboratory at the Radboud University Medical Center, Netherlands)
11:40 – 12:20 Paediatric biomarkers discovery and development TBD
12:20 – 13:20 Lunch break  
Session III: Clinical trial design and implementation
13:20 – 14:00 Pharmacogenetics and pharmacogenomics: their impact on personalised medicine and implementation into clinical practice. Marius Geantă (Center for Innovation in Medicine, Romania)
14:00 – 14:40 Clinical trial objectives, methodology and design in the era of precision medicine TBD
14:40 – 15:00 Break  
Session IV: European Regulatory Environment
15:00 – 15:40 Future perspective of personalised medicine within the regulatory framework TBD
15:40 – 16:20 Ethical challenges of personalised medicine TBD
Registration deadline: 28 October 2021


Should you have any questions about registration, invoices or connection, do not hesitate and contact us by email at This email address is being protected from spambots. You need JavaScript enabled to view it..

By registering to the event, you give your authorisation to the organizers to use your email address and personal information to communicate with you about this event and future initiatives. To stop receiving their communications, please contact the organizers directly at This email address is being protected from spambots. You need JavaScript enabled to view it..